SCHEMBL32683286

SCHEMBL32683286

COC(=O)c1c(C)nn(COCC[Si](C)(C)C)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 1/20 0.38
POLB P06746 2/20 0.35
LMNA P02545 2/20 0.35
NPC1 O15118 1/20 0.35
TSHR P16473 3/20 0.35
KLKB1 P03952 2/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MAPK1 P28482 2/20 0.33
TP53 P04637 1/20 0.33
PDE4D Q08499 1/20 0.33
HTT P42858 1/20 0.33
DGAT1 O75907 1/20 0.33
ALOX15 P16050 1/20 0.32
HBB P68871 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26958676 0.88 PDE4D (0.45) ALDH1A1KMT2AGAALMNAHPGD
SCHEMBL30953634 0.86 POLB (0.48) ALDH1A1KMT2AGAAPOLBLMNA
SCHEMBL14712052 0.80 RAB9A (0.46) KMT2APOLBNPC1TSHRMEN1
SCHEMBL23294652 0.80 MAPT (0.36) ALDH1A1KMT2AL3MBTL1GAAMEN1
SCHEMBL30986487 0.78 HTT (0.34) ALDH1A1KMT2AL3MBTL1POLBNPC1
SCHEMBL21713009 0.78 ALDH1A1 (0.34) ALDH1A1KMT2AL3MBTL1KLKB1DGAT1
SCHEMBL21712932 0.78 ALDH1A1 (0.32) ALDH1A1KMT2AL3MBTL1KLKB1DGAT1
SCHEMBL30986483 0.76 KLKB1 (0.31) ALDH1A1KMT2AL3MBTL1NPC1KLKB1
SCHEMBL16453437 0.76 ALDH1A1 (0.41) ALDH1A1KLKB1DGAT1
SCHEMBL32683408 0.75 KLKB1 (0.35) ALDH1A1POLBLMNANPC1KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260069602-A1 COMPOUNDS, COMPOSITIONS, AND METHODS ACONCAGUA BIO INC (US) 2026-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260069602-A1 COMPOUNDS, COMPOSITIONS, AND METHODS SCTR, SSTR1, NPY1R ALDH1A1 2807/4885KMT2A 4817/4885L3MBTL1 3151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.